Skip to main content

Oncology Code Systems

HER2MethodCS

Description TBD

Code Display
spot-light SPot-Light HER2 CISH test
ihc ImmunoHistoChemistry test
inform Inform HER2 Dual ISH test (In SituHybridization)

DegreeOfLymphaticInvolvementCS

Description TBD

Code Display
microscopic Only a few cancer cells are in the node.
gross The cancer can be seen or felt without aid of microscopy.
extracapsular Cancer has pread outside the wall of the node.

StagingMethodCS

The methodology or standard used to do the staging.

Code Display
ajcc_v7 AJCC Breast Carcinoma Version 7
ajcc_v8 AJCC Breast Carcinoma Version 8

StagingTimeCS

When staging was done, relative to treatment events.

Code Display
clinical On initial diagnosis
pathologic Post-operative, after resection surgery
enrollment When patient is enrolled in a clinical trial
recurrence Upon recurrence of disease

BrcaReceptorStatusCS

Classification of receptor status in breast cancer.

Code Display
luminal_A Group 1. Includes tumors that are ER positive and PR positive, but negative for HER2. Luminal A breast cancers are likely to benefit from hormone therapy and may also benefit from chemotherapy.
luminal_B Group 2. Includes tumors that are ER positive, PR negative and HER2 positive. Luminal B breast cancers are likely to benefit from chemotherapy and may benefit from hormone therapy and treatment targeted to HER2.
HER2_positive Group 3. Includes tumors that are ER negative and PR negative, but HER2 positive. HER2 breast cancers are likely to benefit from chemotherapy and treatment targeted to HER2.
Triple_negative Group 4. Also called basal-like breast cancer, includes tumors that are ER negative, PR negative and HER2 negative. Basal-like breast cancers are likely to benefit from chemotherapy.